Korean study examines the combined impact of aspirin, metformin, and statin’s impact on lung cancer risk – The Cancer Letter
publication date: Sep. 18, 2020Clinical RoundupThe combined use of aspirin, statins, and metformin is associated with decreased lung cancer incidence and mortality, according to a study published in the Journal of Thoracic Oncology, the journal of the International Association for the Study of Lung Cancer.All three medications are common—approximately 35 million people take a statin to control…
